Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN112174957B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112174957B details an efficient Fe(OTf)3-catalyzed route to 5-selenoindoloisoquinolinones, offering a scalable solution for anticancer pharmaceutical intermediates.